MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$613,234K
Net Income
-$89,070K
Net Profit Margin
-14.52%
EPS
-$1.16
Unit: Thousand (K) dollars
Revenue Breakdown
Diabetes Product
Sleep Therapy Product
Home Respiratory Therapy Product
Others
Revenue Breakdown
Commercial Payors
Medicare
Medicaid
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
Net revenue
613,234
627,780
690,508*
Cost of net revenue
349,827
349,752
368,183*
Selling, general and administrative expenses
243,560
255,226
266,890*
Transaction breakage fee
-
-
20,000*
Acquisition-related charges and intangible amortization
29,229
29,229
23,958*
Exit and realignment charges, net
25,768
-23,552
4,612*
Total operating costs and expenses
648,384
610,655
683,643*
Operating loss
-35,150
17,125
6,865*
Interest expense, net
-34,539
32,348
26,796*
Transaction financing fees, net
-
-
4,572*
Loss on modification and extinguishment of debt
-17,296
-
-
Other expense, net
-643
-1,023
-985*
Loss from continuing operations before income taxes
-87,628
-16,246
-25,488*
Income tax provision (benefit)
1,442
-9,778
182*
Loss from continuing operations, net of tax
-89,070
-6,468
-25,670*
Net revenue
-
-
1,977,414*
Cost of goods sold
-
-
1,781,286*
Gross profit
-
-
196,128*
Distribution, selling, and administrative expenses
-
-
195,697*
Acquisition-related charges and intangible amortization
-
-
3,137*
Exit and realignment charges, net
-
-
18,095*
Goodwill impairment charge
-
-
26,597*
Loss on classification to held for sale
-
-
199,732*
Other operating expense, net
-
-
-2,733*
Operating (loss) income
-
-
-249,864*
Interest expense, net
-
-
-9,000*
Other expense
-
-
351*
Loss from discontinued operations before income taxes
-
-
-259,216*
Income tax benefit for discontinued operations
-
-
-9,727*
Loss from discontinued operations, net of tax
-
-
-249,489*
Net loss
-89,070
-6,468
-275,160
Basic EPS
-1.16
-0.08
-3.578
Diluted EPS
-1.16
-0.08
-3.578
Basic Average Shares
76,695,000
76,432,000
76,897,000
Diluted Average Shares
76,695,000
76,432,000
76,897,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Net loss
-$89,070K
Loss from continuing
operations, net of tax
-$89,070K
Loss from continuing
operations before income...
-$87,628K
Income tax provision
(benefit)
$1,442K
Diabetes Product
$198,820K
Sleep Therapy Product
$148,575K
Home Respiratory
Therapy Product
$90,996K
Ostomy
$55,675K
Product And Service
Other
$47,680K
Wound Care
$40,193K
Urology
$31,295K
Operating loss
-$35,150K
Interest expense, net
-$34,539K
Loss on modification
and extinguishment...
-$17,296K
Other expense, net
-$643K
Net revenue
$613,234K
Total operating costs
and expenses
$648,384K
Cost of net revenue
$349,827K
Selling, general and
administrative expenses
$243,560K
Acquisition-related charges and
intangible amortization
$29,229K
Exit and realignment
charges, net
$25,768K
Buy us a coffee
ACCENDRA HEALTH INC VA (ACH)
ACCENDRA HEALTH INC VA (ACH)